Preliminary study of a new anti-parkinson agent.
D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders
D009125:Muscle Relaxants, Central
MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy